NP000888

· Galderma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NP000888, covering 2018-06-12 to 2018-06-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis [Phase 2]